Loading clinical trials...
Loading clinical trials...
A Phase 1/2, Open-Label Clinical Study To Evaluate Safety And Efficacy Of TP-0184 To Treat Anemia When Administered To Adult Patients With IPSS-R Low Or Intermediate Risk Myelodysplastic Syndromes
Conditions
Interventions
TP-0184
Locations
3
United States
BRCR Global
Plantation, Florida, United States
Montefiore Medical Center
The Bronx, New York, United States
US Oncology - Austin Texas Oncology Midtown
Austin, Texas, United States
Start Date
December 28, 2020
Primary Completion Date
April 27, 2021
Completion Date
April 27, 2021
Last Updated
November 9, 2023
Lead Sponsor
Sumitomo Pharma America, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions